BioSyntech

Tempothera

This biotechnology company develops synthetic microporous scaffolds for tissue engineering and regenerative medicine applications for patients undergoing surgical reconstruction.

AmacaThera

The company develops injectable hydrogel drug delivery platforms for pharmaceutical partners to provide sustained post-surgical pain management and localised therapeutic release.

TYBR Health

This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.

InGel Therapeutics

The company develops stem-cell therapies and biodegradable hydrogels for patients suffering from retinal degeneration and blinding diseases like retinitis pigmentosa.

SynsoryBio

SynsoryBio develops protein therapeutics designed to sense specific disease markers and activate only at targeted tissues to treat cancer and autoimmune disorders.

AMR Bio

This biotechnology company develops topical antimicrobial gels to prevent post-surgical infections for healthcare providers and patients undergoing surgery.

Exostemtech

This biotechnology firm develops exosome-based therapeutics and production platforms for clinical researchers and healthcare providers treating intractable diseases.

Brixton Biosciences

This life sciences company develops a nerve-selective injectable biomaterial that provides long-lasting, drug-free pain relief for patients suffering from chronic and acute orthopedic conditions.